Research Frontiers(REFR) 2023 Earnings Summary
Bullish Points:
1. Fee income from licensing activities for Q2 2023 was $185,040, compared to $85,511 for Q2 2022, primarily due to higher royalties from automotive and aircraft markets.
2. Operating expenses decreased by $117,545 for Q2 2023 to $564,694 from $682,239 for Q2 2022, mainly due to lower bad debts and patent costs.
3. Research and development expenditures decreased slightly by $822 to $145,610 for Q2 2023 from $146,432 for Q2 2022.
4. Net investment income for Q2 2023 was $31,614, compared to $1,322 for Q2 2022, primarily due to changes in market values of marketable securities and higher interest rates.
5. The company received proceeds of $484,502 from the exercise of warrants covering 358,891 shares of common stock during the six months ended June 30, 2023.
6. The company entered into subscription agreements to sell 2 million shares of common stock at $2.30 per share and received $3,450,000 under these agreements as of September 30, 2022.
7. Company expects revenue in all market segments to increase further as new car models and other products using the Company’s SPD-SmartGlass technology are introduced into the market.
Bearish Points:
1. For the quarter ended June 30, 2023, the company reported a net loss of $493,650.
2. Total operating expenses for the quarter were $710,304.
3. As of June 30, 2023, the company had an accumulated deficit of approximately $123.3 million.
4. The company's projected cash flow shortfall for the next 12 months is approximately $200,000 to $250,000 per quarter.
In summary, Research Frontiers (REFR) has shown improvements in fee income, operating expenses, and net investment income. However, the company still reported a net loss for the quarter and has a projected cash flow shortfall for the next 12 months. The eventual success of the company will depend on the commercialization of products using its technology and the generation of sufficient revenue from its licensees. For more information, you can read the original text of Research Frontiers' financial report: https://www.sec.gov/Archives/edgar/data/793524/000149315223026617/form10-q.htm
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
